Whoa. Agios Pharmaceuticals (AGIO)'s Experimental Cancer Drug Makes Cancer Undetectable In Three Patients
4/7/2014 7:31:23 AM
Agios, a biotechnology company based in Cambridge, Mass., has seemed in some ways a sign of the overexcitement of the recent biotech boom. After all, the company, despite an experienced management team, a July public stock offering that raised more than $100 million, and great scientific ideas, hasn’t been able to show a single result from testing its drugs in humans.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by